|
|
Article: 'Zomig' Nasal Spray Provides Relief in Adolescent Migraine.
- Article from:
- PR Newswire Europe
- Article date:
- June 24, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA, Pennsylvania, June 24 /PRNewswire/ -- New clinical trial data presented today at the 47th American Headache Society Annual Scientific meeting shows that zolmitriptan ('Zomig') 5 mg nasal spray is highly effective and well tolerated in the acute treatment of adolescent migraine(1).
Results of the study show that zolmitriptan nasal spray has significantly higher headache response than placebo after one hour (58.1% vs. 43.3%; p
Dr Paul Winner from the Palm Beach Headache Centre, Florida commented, "These results are very significant for the future management of migraine, as we now have conclusive evidence that migraine in adolescents can be ...